127 related articles for article (PubMed ID: 37796182)
1. Small Bowel Metastases From Malignant Phyllodes Breast Tumor Detected by 18 F-FDG PET/CT.
Yuan M; Han B; Zhang N; Lu L; Liu S
Clin Nucl Med; 2023 Nov; 48(11):967-968. PubMed ID: 37796182
[TBL] [Abstract][Full Text] [Related]
2. Rare Case of Phyllodes Tumor of Breast with Cardiac and Pancreatic Metastases: Findings on
Singh P; Parida GK; Singhal T; Kumar P; Bishnoi K; Agrawal K
J Nucl Med Technol; 2023 Jun; 51(2):156-157. PubMed ID: 36750379
[TBL] [Abstract][Full Text] [Related]
3. A pulmonary metastasis of a cystosarcoma phyllodes of the breast detected by 18F-FDG PET/CT.
Treglia G; Muoio B; Caldarella C; Parapatt GK
Clin Nucl Med; 2014 Mar; 39(3):e233-5. PubMed ID: 23603592
[TBL] [Abstract][Full Text] [Related]
4. 68 Ga-DOTA-FAPI-04 Imaging of Bilateral Phyllodes Tumor.
Alçın G; Arslan E; Baykara Ulusan M; Aksoy T; Ergül N; Çermik TF
Clin Nucl Med; 2023 Oct; 48(10):e480-e482. PubMed ID: 37565817
[TBL] [Abstract][Full Text] [Related]
5. 18 F-FDG PET/CT Versus 18 F-FAPI PET/CT in a Case of Recurrent Malignant Phyllodes Breast Tumor.
Jiang S; Jiang M; Rao S; Liang J; Zhang R
Clin Nucl Med; 2024 Jan; 49(1):e35-e37. PubMed ID: 37962169
[TBL] [Abstract][Full Text] [Related]
6. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
7. Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis.
Zhang C; Liang Z; Liu W; Zeng X; Mo Y
BMC Cancer; 2023 Jan; 23(1):37. PubMed ID: 36624425
[TBL] [Abstract][Full Text] [Related]
8.
Wang H; Xue Y; Xu H
Breast J; 2021 Feb; 27(2):183-184. PubMed ID: 33368827
[No Abstract] [Full Text] [Related]
9. Factors affecting the accuracy of
Kutluturk K; Simsek A; Comak A; Gonultas F; Unal B; Kekilli E
Niger J Clin Pract; 2019 Jan; 22(1):63-68. PubMed ID: 30666022
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. F-18 FDG whole-body positron emission tomography scan in primary breast sarcoma.
Bakheet SM; Powe J; Ezzat A; Al Suhaibani H; Tulbah A; Rostom A
Clin Nucl Med; 1998 Sep; 23(9):604-8. PubMed ID: 9735983
[TBL] [Abstract][Full Text] [Related]
12. [Malignant phyllodes tumor of the breast with lymph node metastases shown by FDG PET-CT].
Santiago Chinchilla A; Ramos Font C; Custodio Rebollo Aguirre A; Navarro-Pelayo Láinez M; Palacios Gerona H; Llamas Elvira JM
Rev Esp Med Nucl; 2010; 29(6):314-5. PubMed ID: 20692076
[No Abstract] [Full Text] [Related]
13. Comparison of
Mori M; Fujioka T; Ichikawa R; Inomata R; Katsuta L; Yashima Y; Yamaga E; Tsuchiya J; Hayashi K; Kumaki Y; Oda G; Nakagawa T; Onishi I; Kubota K; Tateishi U
Tomography; 2022 Oct; 8(5):2533-2546. PubMed ID: 36287810
[TBL] [Abstract][Full Text] [Related]
14. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging.
Mittal BR; Manohar K; Kashyap R; Bhattacharya A; Singh B; Singh G
Hell J Nucl Med; 2011; 14(2):135-9. PubMed ID: 21761015
[TBL] [Abstract][Full Text] [Related]
15. Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?
Caglar M; Kupik O; Karabulut E; Høilund-Carlsen PF
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):3-11. PubMed ID: 26514321
[TBL] [Abstract][Full Text] [Related]
16. Head-to-Head Evaluation of
Ulaner GA; Jhaveri K; Chandarlapaty S; Hatzoglou V; Riedl CC; Lewis JS; Mauguen A
J Nucl Med; 2021 Mar; 62(3):326-331. PubMed ID: 32680923
[TBL] [Abstract][Full Text] [Related]
17. PET/CT in breast cancer staging is useful for evaluation of axillary lymph node and distant metastases.
Davidson T; Shehade N; Nissan E; Sklair-Levy M; Ben-Haim S; Barshack I; Zippel D; Halevy A; Chikman B
Surg Oncol; 2021 Sep; 38():101567. PubMed ID: 33866190
[TBL] [Abstract][Full Text] [Related]
18. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.
Alberini JL; Lerebours F; Wartski M; Fourme E; Le Stanc E; Gontier E; Madar O; Cherel P; Pecking AP
Cancer; 2009 Nov; 115(21):5038-47. PubMed ID: 19645022
[TBL] [Abstract][Full Text] [Related]
19. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
[TBL] [Abstract][Full Text] [Related]
20. F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma.
Ottenhof SR; Djajadiningrat RS; Versleijen MWJ; Donswijk ML; van der Noort V; Brouwer OR; Graafland NM; Vegt E; Horenblas S
Eur Urol Focus; 2022 Jan; 8(1):98-104. PubMed ID: 33685842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
